English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1802]
News [2707]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Researchers develop non-invasive technique for predicting patients’ response to chemotherapy
Researchers develop non-invasive technique for predicting patients’ response to chemotherapy
Scientists test 5000 combinations of 100 existing cancer drugs to find more effective treatments
Scientists test 5000 combinations of 100 existing cancer drugs to find more effective treatments
NCRI 2012: Highlights from Monday 5 November
NCRI 2012: Highlights from Monday 5 November
Experimental combination therapy trial for breast cancer patients no longer responding to treatment
Experimental combination therapy trial for breast cancer patients no longer responding to treatment
Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy
Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy
ASTRO 2012: Combination of surgery and adjuvant radiation treatment shows improved survival
ASTRO 2012: Combination of surgery and adjuvant radiation treatment shows improved survival
Concurrent use of sorafenib and stereotactic body radiotherapy for advanced liver cancer patients not recommended outside of trials
Concurrent use of sorafenib and stereotactic body radiotherapy for advanced liver cancer patients not recommended...
Weight, age, and gender affect duration, intensity of toxicity for stem cell donors
Weight, age, and gender affect duration, intensity of toxicity for stem cell donors
Proteins in DNA damage response network targeted for new therapies
Proteins in DNA damage response network targeted for new therapies
Melanomas become resistant to therapy through inflammation-induced  dedifferentiation
Melanomas become resistant to therapy through inflammation-induced dedifferentiation
<1...263264265266267...271>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top